LILogien Abuelgasim Ahmad Ibrahim

Logien Abuelgasim Ahmad Ibrahim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Research Subjects

Research Interests


Logien Abuelgasim Ahmad Ibrahim has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prevalence of maladaptive daydreaming and its association with dissociative experiences among Pakistani medical students: a cross-sectional study

    by Maham Khan, Tehreem Rauf, Fajar Khurram, Minahil Shakoor, Syeda Maryam Mathoor, Hira Akram, Khansa Saeeda, Ume Rubab, Zain Ul Abedin, Javeria Akhter, et al.

  • Open Access

    Assessment of asthma care, self-management and healthcare services access during the Sudanese war: a cross-sectional survey

    by Roaa N S Osman, Logien Abuelgasim Ahmad Ibrahim, Reela H Moubarak, Alaa A S Salih, Abdelwahab G A Mahmoud, Shroog M K Hassan, Amna A A Elshikh, Sohaib Mohammed Mokhtar Ahmed, Sara F I Khalil, Darelsalam Ishag Ateem Abdelrasoul, et al.

    Background: Asthma poses a great burden as one of the most common long-term non-communicable diseases. The April 2023 Sudanese war has severely disrupted the healthcare system, greatly affecting asthmatic patients by limiting access to medications and diagnostic services. Therefore, this research aims to investigate asthma control, self-management and healthcare access among asthma patients in Sudan during the ongoing war. Methods: A cross-sectional study was conducted among Sudanese patients with asthma during the ongoing war using a convenience sampling. An online questionnaire was distributed from September 2024 to June 2025. It covered sociodemographic data, the validated Asthma Control Test (ACT), self-management and healthcare access. Data were analysed using SPSS software, employing descriptive statistics, χ 2 tests and linear regression, with significance set at p<0.05. Results: Among the 229 asthmatic patients surveyed, 60.3% had poorly controlled asthma. Since the onset of the conflict, 43.2% had not attended any follow-up visits, while 48.5% required at least one emergency room visit during the war. Despite these challenges, 86.0% reported having quick access to healthcare during active attacks. However, 17.9% were unable to obtain their medications regularly, forcing many to adopt alternative coping strategies: 6.1% sought medical advice through online consultations, 15.7% increased their prescribed doses on their own and 39.3% used whatever medications were available without prescriptions, which was significantly associated with poor asthma control (χ²=29.29, p<0.01). Regression analysis revealed dose reduction was linked to worse control (β=−3.68, p=0.004), while refugee status and better adherence to medications predicted higher ACT scores (β=2.88, p<0.001; β=0.54, p=0.028). Conclusions: This study highlights a considerable gap in asthma control during the ongoing war, despite the availability of healthcare services in times of urgent need. Many patients adopted coping strategies such as using whatever medications were available without prescriptions or independently increasing their prescribed doses. Enhancing patient education on proper asthma self-management and improving access to healthcare services, including telemedicine consultations, could play a crucial role in achieving better asthma control.


  • Open Access

    The power of cognitive rehabilitation in Alzheimer’s disease ‐A Systematic review and meta analysis

    by Logien Abuelgasim Ahmad, Mostafa A. Khalifa, Mohammed Alaa Hashad

    Background: Alzheimer’s disease (AD) is a challenging condition that forbids individuals of their memories and abilities to carry out their daily functioning. In the research for solutions, cognitive rehabilitation (CR) has emerged as a promising intervention to help individuals with Alzheimer’s disease improve their daily activities. Despite its potential benefits, the effectiveness of clinical trials (CT) remains a mystery, inconclusive further investigation. In this study, we aim to unravel the potential of CR in enhancing the lives of individuals with AD, with a focus on evaluating whether CR leads to meaningful enhancements in daily functioning as assessed by validated measures.Method: Our research is based on the PRISMA guidelines, and to identify relevant studies, a comprehensive search was conducted across multiple databases, including PubMed, Cochrane Library, Scopus, and Web of Science Keywords were used for searching, from inception to 2024. The research was limited to randomized controlled trials examining the effects of cognitive rehabilitation, including a total of 14 clinical trial articles, excluding studies focusing on cognitive stimulation, cognitive training, or cognitive intervention. Non‐English language articles and populations with diagnoses of other conditions are also excluded.Result: Our systematic reviews yielded a total of 1919 studies. After removing 287 duplicate records, we screened the title and abstract of 1877 papers, excluding 1835. Then, we proceeded to review the full text of 42 articles. 14 of them met the inclusion criteria. A pilot study of four papers is underway, and its results are expected to add to the existing evidence on the effectiveness of cognitive rehabilitation in AD. The meta‐analysis results for other domains of cognitive functions were not statistically complete yet. Further research is warranted to confirm these findings.Conclusion: Cognitive rehabilitation demonstrated significant positive effects on quality of life and occupational performance in patients with Alzheimer’s disease. Further, research is needed to investigate the efficiency of the intervention in specific domains to enhance understanding of Alzheimer’s disease management.